IL137990A0 - A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof - Google Patents
A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereofInfo
- Publication number
- IL137990A0 IL137990A0 IL13799099A IL13799099A IL137990A0 IL 137990 A0 IL137990 A0 IL 137990A0 IL 13799099 A IL13799099 A IL 13799099A IL 13799099 A IL13799099 A IL 13799099A IL 137990 A0 IL137990 A0 IL 137990A0
- Authority
- IL
- Israel
- Prior art keywords
- angiotensin
- type
- pharmaceutical preparation
- receptor agonist
- agonist
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9800550A SE9800550D0 (en) | 1998-02-24 | 1998-02-24 | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |
PCT/SE1999/000262 WO1999043339A1 (en) | 1998-02-24 | 1999-02-24 | A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL137990A0 true IL137990A0 (en) | 2001-10-31 |
Family
ID=20410283
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13799099A IL137990A0 (en) | 1998-02-24 | 1999-02-24 | A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1066048A1 (en) |
JP (1) | JP2002504516A (en) |
KR (1) | KR20010041211A (en) |
CN (1) | CN1291104A (en) |
AU (1) | AU755949B2 (en) |
BR (1) | BR9908188A (en) |
CA (1) | CA2319123A1 (en) |
EE (1) | EE200000481A (en) |
HU (1) | HUP0101411A3 (en) |
ID (1) | ID26639A (en) |
IL (1) | IL137990A0 (en) |
IS (1) | IS5594A (en) |
MX (1) | MXPA00008172A (en) |
NO (1) | NO20004215L (en) |
NZ (1) | NZ506188A (en) |
SE (1) | SE9800550D0 (en) |
SK (1) | SK11522000A3 (en) |
WO (1) | WO1999043339A1 (en) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6821953B1 (en) | 1999-12-16 | 2004-11-23 | University Of Southern California | Methods for treating and preventing damage to mucosal tissue |
EP1239867B1 (en) * | 1999-12-16 | 2005-01-26 | University of Southern California | Methods for treating and preventing damage to mucosal tissue |
DK1395566T3 (en) | 2001-05-31 | 2008-01-07 | Vicore Pharma Ab | Tricyclic compounds useful as angiotensin II agonists |
MX2007012635A (en) | 2005-04-12 | 2008-01-11 | Vicore Pharma Ab | New tricyclic angiotensin ii agonists. |
CA2603254C (en) | 2005-04-12 | 2013-10-29 | Vicore Pharma Ab | New bicyclic angiotensin ii agonists |
DK1869023T3 (en) | 2005-04-12 | 2012-04-10 | Vicore Pharma Ab | Novel tricyclic angiotensin II agonists |
US20080317670A1 (en) * | 2005-12-14 | 2008-12-25 | Ambrx, Inc. | Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
US8835471B2 (en) | 2010-06-11 | 2014-09-16 | Vicore Pharma Ab | Use of angiotensin II agonists |
EP2455388A1 (en) | 2010-11-23 | 2012-05-23 | LanthioPep B.V. | Novel angiotensin type 2 (AT2) receptor agonists and uses thereof. |
US20150119329A1 (en) * | 2012-04-16 | 2015-04-30 | New York University | Modulation of angiotensin ii receptors for the prevention and treatment of malaria cerebral |
JP2018507244A (en) | 2015-03-02 | 2018-03-15 | ビーコレ ファルマ アクティエボラーグ | Angiotensin II receptor agonists for the treatment of pulmonary fibrosis |
WO2017221012A1 (en) | 2016-06-21 | 2017-12-28 | Vicore Pharma Ab | Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity |
GB201818164D0 (en) | 2018-11-07 | 2018-12-19 | Vicore Pharma Ab | New composition |
WO2021023698A1 (en) | 2019-08-02 | 2021-02-11 | Lanthiopep B.V | Angiotensin type 2 (at2) receptor agonists for use in the treatment of cancer |
GB201913603D0 (en) | 2019-09-20 | 2019-11-06 | Vicore Pharma Ab | New compounds |
EP4121165A1 (en) | 2020-03-19 | 2023-01-25 | Vicore Pharma AB | Novel compounds useful in the treatment and/or prevention of a disease, disorder or condition associated with angiotensin ii |
GB202004094D0 (en) | 2020-03-20 | 2020-05-06 | Vicore Pharma Ab | New compounds and uses |
GB202006074D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
GB202006081D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
GB202006079D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
GB202013721D0 (en) | 2020-09-01 | 2020-10-14 | Vicore Pharma Ab | New compounds |
WO2022200785A1 (en) | 2021-03-23 | 2022-09-29 | Vicore Pharma Ab | Selective angiotensin ii receptor ligands |
GB202104033D0 (en) | 2021-03-23 | 2021-05-05 | Vicore Pharma Ab | New compounds |
GB202104038D0 (en) | 2021-03-23 | 2021-05-05 | Vicore Pharma Ab | New compounds |
WO2023281271A1 (en) | 2021-07-09 | 2023-01-12 | Vicore Pharma Ab | New selective angiotensin ii compounds |
GB202115303D0 (en) | 2021-10-25 | 2021-12-08 | Vicore Pharma Ab | New formulation |
GB202201723D0 (en) | 2022-02-10 | 2022-03-30 | Vicore Pharma Ab | New use |
AU2023217949A1 (en) | 2022-02-10 | 2024-08-15 | Vicore Pharma Ab | Use of buloxibutid for the treatment of idiopathic pulmonary fibrosis |
WO2024133942A1 (en) | 2022-12-22 | 2024-06-27 | Vicore Pharma Ab | A method of treating a patient diagnosed with an interstitial lung disease |
WO2024149712A1 (en) | 2023-01-09 | 2024-07-18 | Vicore Pharma Ab | Selective angiotensin ii compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5444067A (en) * | 1993-08-30 | 1995-08-22 | Merck & Co., Inc. | Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety |
AU3708295A (en) * | 1994-11-04 | 1996-05-31 | Stefan L. Marklund | Use of receptor agonists to stimulate superoxide dismutase activity |
SE9501881D0 (en) * | 1995-05-19 | 1995-05-19 | Astra Ab | New pharmacological use of AII receptor antagonists |
US5834432A (en) * | 1995-06-06 | 1998-11-10 | The University Of Southern California | Use of angiotensin II Type 2 receptor agonists in tissue repair |
SE9502219D0 (en) * | 1995-06-19 | 1995-06-19 | Astra Ab | Novel medical use |
-
1998
- 1998-02-24 SE SE9800550A patent/SE9800550D0/en unknown
-
1999
- 1999-02-24 AU AU27537/99A patent/AU755949B2/en not_active Ceased
- 1999-02-24 SK SK1152-2000A patent/SK11522000A3/en unknown
- 1999-02-24 EE EEP200000481A patent/EE200000481A/en unknown
- 1999-02-24 WO PCT/SE1999/000262 patent/WO1999043339A1/en not_active Application Discontinuation
- 1999-02-24 MX MXPA00008172A patent/MXPA00008172A/en unknown
- 1999-02-24 KR KR1020007009295A patent/KR20010041211A/en not_active Application Discontinuation
- 1999-02-24 JP JP2000533135A patent/JP2002504516A/en active Pending
- 1999-02-24 ID IDW20001909A patent/ID26639A/en unknown
- 1999-02-24 HU HU0101411A patent/HUP0101411A3/en unknown
- 1999-02-24 CN CN99803230A patent/CN1291104A/en active Pending
- 1999-02-24 CA CA002319123A patent/CA2319123A1/en not_active Abandoned
- 1999-02-24 BR BR9908188-1A patent/BR9908188A/en not_active IP Right Cessation
- 1999-02-24 EP EP99908017A patent/EP1066048A1/en not_active Withdrawn
- 1999-02-24 NZ NZ506188A patent/NZ506188A/en unknown
- 1999-02-24 IL IL13799099A patent/IL137990A0/en unknown
-
2000
- 2000-08-21 IS IS5594A patent/IS5594A/en unknown
- 2000-08-23 NO NO20004215A patent/NO20004215L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20010041211A (en) | 2001-05-15 |
SE9800550D0 (en) | 1998-02-24 |
MXPA00008172A (en) | 2002-06-21 |
CA2319123A1 (en) | 1999-09-02 |
HUP0101411A2 (en) | 2002-03-28 |
NO20004215L (en) | 2000-09-18 |
ID26639A (en) | 2001-01-25 |
EP1066048A1 (en) | 2001-01-10 |
NO20004215D0 (en) | 2000-08-23 |
WO1999043339A1 (en) | 1999-09-02 |
IS5594A (en) | 2000-08-21 |
AU755949B2 (en) | 2003-01-02 |
EE200000481A (en) | 2002-02-15 |
NZ506188A (en) | 2003-04-29 |
BR9908188A (en) | 2000-10-24 |
AU2753799A (en) | 1999-09-15 |
SK11522000A3 (en) | 2001-04-09 |
JP2002504516A (en) | 2002-02-12 |
HUP0101411A3 (en) | 2002-11-28 |
CN1291104A (en) | 2001-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL137990A0 (en) | A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof | |
HUP0100266A3 (en) | 1-amino-alkylcyclohexane nmda receptor antagonists, pharmaceutical compositions containing the compounds and their preparations | |
AU3080499A (en) | Analgesic combination comprising nmda receptor antagonists and narcotic analgesics | |
EP1112252A4 (en) | Kappa agonist compounds and pharmaceutical formulations thereof | |
SI1019358T2 (en) | 3,3-diarylpropylamines , their use and preparation | |
IL138576A0 (en) | A novel interleukin-1 receptor antagonist and uses thereof | |
GB9809933D0 (en) | Drug delivery device | |
CZ2000522A3 (en) | Pharmaceutical preparation based on piperidinalkanol antihistaminic and use thereof | |
ZA200203178B (en) | New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist. | |
GB9823245D0 (en) | Pectins and the preparation thereof | |
EP0838471A4 (en) | Peptide derivatives and angiotensin iv receptor agonist | |
PL343152A1 (en) | 3',3'-n-bis-substituted macrolide lhrh antagonists | |
AU1744700A (en) | Human neurotensin subtype 2 receptor | |
AU5861900A (en) | Receptor agonists and antagonists | |
HUP0001490A3 (en) | Pesticidal 1-arylpyrazole derivatives, preparation and use thereof | |
GB9820014D0 (en) | Receptor antagonists and uses thereof | |
HUP0000491A3 (en) | Herbicidal substituted 4-benzoyl-pyrazole derivatives, preparation and use thereof | |
AU3935897A (en) | B1-bradykinin receptor antagonists and use thereof | |
AU2003202455A1 (en) | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof | |
GB2324090B (en) | 5,6-O-alkylidene glucono-1(4)-lactones and derivatives thereof,their preparation and use | |
AU2001280969A1 (en) | 18610, a human transient receptor and uses thereof | |
IL136230A0 (en) | An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes | |
AUPP058597A0 (en) | Receptor agonists and antagonists | |
PL345949A1 (en) | Novel angiotensin receptor, production and use thereof | |
GB9719843D0 (en) | Intergrin antagonists |